|
C10ORF78 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.456300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.332400E-02 |
| Normal-vs-Stage2 |
7.745700E-02 |
| Normal-vs-Stage3 |
4.054000E-01 |
| Normal-vs-Stage4 |
4.115900E-02 |
| Stage1-vs-Stage2 |
4.850000E-01 |
| Stage1-vs-Stage3 |
3.652600E-01 |
| Stage1-vs-Stage4 |
2.889400E-01 |
| Stage2-vs-Stage3 |
2.407800E-01 |
| Stage2-vs-Stage4 |
8.126600E-01 |
| Stage3-vs-Stage4 |
1.961620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.624100E-02 |
| Normal-vs-AfricanAmerican |
1.303920E-02 |
| Normal-vs-Asian |
5.089200E-01 |
| Caucasian-vs-AfricanAmerican |
1.986180E-01 |
| Caucasian-vs-Asian |
8.391000E-01 |
| AfricanAmerican-vs-Asian |
5.474600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.581700E-02 |
| Normal-vs-Female |
1.659910E-02 |
| Male-vs-Female |
3.749600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.448420E-01 |
| Normal-vs-Extreme_Weight |
6.428200E-02 |
| Normal-vs-Obese |
2.811700E-02 |
| Normal-vs-Extreme_Obese |
4.520200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.302200E-01 |
| Normal_Weight-vs-Obese |
5.336400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.470600E-01 |
| Extreme_Weight-vs-Obese |
4.918600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.824400E-01 |
| Obese-vs-Extreme_Obese |
7.797600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.911500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.940440E-03 |
| Normal-vs-Age(61-80Yrs) |
9.056400E-02 |
| Normal-vs-Age(81-100Yrs) |
8.184400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.057200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.815200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.620800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.008200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.521900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.777800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.642100E-03 |
| Normal-VS-Type2 PRCC |
8.538200E-01 |
| Normal-VS-KIRP CIMP |
4.531400E-01 |
| Normal-VS-Unclassified PRCC |
1.155920E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.89938999999306E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.147000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.493200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.803200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.597040E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.443400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.459600E-01 |
| Normal-vs-N1 |
6.476200E-02 |
| Normal-vs-N2 |
3.104000E-01 |
| N0-vs-N1 |
2.047800E-01 |
| N0-vs-N2 |
7.215200E-01 |
| N1-vs-N2 |
8.130200E-01 |
|
|
